A little-known biotech company stunned the biopharmaceutical industry last spring when it declared an "unprecedented" achievement: its experimental cancer drug looked more effective than Merck's ...

Climate change-driven extreme weather events threaten the US pharmaceutical supply chain, with 62.8% of facilities in disaster-prone counties. Hurricane Helene in 2024 highlighted the vulnerability of ...

Scientists have developed a new strategy to enhance pharmaceutical production in Chinese hamster ovary (CHO) cells, which are commonly used to manufacture protein-based drugs for treating cancer, ...

As the U.S. focuses on beefing up its biopharma manufacturing infrastructure this year, a similar effort toward improved drug shortage resilience has been playing out across the pond. Now, following a ...

Tariffs on pharmaceutical companies isn't just good economic policy - it benefits national security and public health More than 90% of U.S. prescriptions are for generic drugs, yet more than 80% of ...

The demand for the widely used cancer drug Taxol is increasing, but it's difficult and expensive to produce because it hasn't been possible to do it biosynthetically. Until now, that is. Researchers ...

Stream NBC 5 for free, 24/7, wherever you are. In October, a group of life science investors announced they were putting $400 million into creating a company called Kailera Therapeutics that would ...